Viromed Medical AG | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Viromed Medical AG

BRIEF

published on 09/23/2025 at 11:13, 2 months 11 days ago

Viromed Medical AG Seeks Approval for PulmoPlas®

Antimicrobial Resistance Viromed Medical AG Cold Plasma Technology PulmoPlas® BfArM Approval
PRESS RELEASE

published on 09/23/2025 at 11:08, 2 months 11 days ago

Viromed Medical AG initiates approval process for PulmoPlas® with the Federal Institute for Drugs and Medical Devices (BfArM)
Viromed Medical AG initiates approval process for PulmoPlas® with the Federal Institute for Drugs and Medical Devices (BfArM), aiming to combat ventilator-associated pneumonia and antimicrobial resistance

Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Technology Approval Process PulmoPlas
BRIEF

published on 09/18/2025 at 10:28, 2 months 16 days ago

Viromed Medical AG Secures ISO 13485 Certification for ViroCAP® Launch

ISO 13485 Certification Viromed Medical AG Cold Plasma Technology ViroCAP® Launch Medical Device Manufacturer
PRESS RELEASE

published on 09/18/2025 at 10:23, 2 months 16 days ago

Viromed Medical AG: Successful ISO 13485 certification paves the way for market launch of ViroCAP® in October 2025
Viromed Medical AG receives ISO 13485 certification, enabling market launch of ViroCAP® in October 2025 for dermatology, wound treatment, and veterinary use

Medical Devices ISO 13485 Certification Viromed Medical AG Market Launch ViroCAP
BRIEF

published on 07/29/2025 at 14:13, 4 months 6 days ago

Viromed Medical AG Approves Resolutions at Annual General Meeting

Annual General Meeting Supervisory Board Shareholder Resolutions Viromed Medical AG Cold Plasma Technology
PRESS RELEASE

published on 07/29/2025 at 14:08, 4 months 6 days ago

Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority
Viromed Medical AG's Annual General Meeting approves all proposed resolutions by a large majority. New Supervisory Board member elected, authorised capital replaced, and focus on innovation highlighted

Annual General Meeting Resolutions Strategic Direction Viromed Medical AG Cold Plasma Technology
BRIEF

published on 07/24/2025 at 09:35, 4 months 11 days ago

Viromed Medical AG Teams Up with TriPart for Product Launch in Turkey

Medical Devices Viromed Medical AG Cold Plasma Technology TriPart Partnership Market Expansion Turkey
PRESS RELEASE

published on 07/24/2025 at 09:30, 4 months 11 days ago

Viromed Medical AG enters into a distribution partnership with TriPart for the market launch of ViroCAP® and PulmoPlas® in Turkey
Viromed Medical AG partners with TriPart for market launch of ViroCAP® and PulmoPlas® in Turkey. New distribution agreement to introduce innovative medical technology products in Q1 2026

Distribution Partnership Viromed Medical AG ViroCAP PulmoPlas TriPart
BRIEF

published on 06/30/2025 at 15:41, 5 months 4 days ago

Viromed Medical AG Projects Significant Growth for 2025 and 2026

Revenue Growth Product Launch Viromed Medical AG Cold Plasma Technology Pharmedix Acquisition
PRESS RELEASE

published on 06/30/2025 at 15:36, 5 months 4 days ago

EQS-Adhoc: Viromed Medical AG expects dynamic growth and announces forecast for 2025 and 2026
Viromed Medical AG expects dynamic growth with revenue forecasted to reach around EUR 8-10 million in 2025 and around EUR 80 million in 2026. The EBIT margin is expected to be in the double-digit range from 2026 onwards

Revenue Forecast Dynamic Growth Financial Projections Viromed Medical AG Cold Plasma Technology

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 46 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 51 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 21 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 16 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 21 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 51 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 30 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 56 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 6 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 10 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 21 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 36 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 37 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 20 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE